A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

A nurse has warned about a common Mounjaro ‘mistake’ that can increase people’s risk of deadly organ damage.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. ... like high blood pressure or high cholesterol. Professor Louis Aronne from Weill Cornell Medicine.

The mass rollout of weight loss injections on the NHS in England began in June. It means GPs are allowed to prescribe the ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years in ... (such as high blood pressure, type 2 diabetes or high ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...

The researchers found that participants who lost at least 35% of their body weight from baseline to week 72 had mean changes of up to –14.2 and –9.2 mm Hg for systolic and diastolic blood ...